Male sex and the pattern of recurrent myeloid mutations are strong independent predictors of blood transfusion intensity in patients with myelodysplastic syndromes

Leukemia. 2019 Feb;33(2):522-527. doi: 10.1038/s41375-018-0256-0. Epub 2018 Sep 28.

Jenny Rydén^{1

2}, Gustaf Edgren^{3

4}, Mohsen Karimi¹, Gunilla Walldin¹, Magnus Tobiasson^{1

2}, Agneta Wikman^{5

6}, Eva Hellström-Lindberg^{1

2}, Petter Höglund^{7

8}

¹ Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
² Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Cardiology, Södersjukhuset, Stockholm, Sweden.
⁵ Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Laboratory Medicine, Karolinska University Hospital, Stockholm, Sweden.
⁷ Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Petter.Hoglund@ki.se.
⁸ Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden. Petter.Hoglund@ki.se.

No abstract available

Publication types